Albert Labs International Corp.
ABRT
CNSX
Weiss Ratings | ABRT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Unrated | |||
Risk Index | Unrated | |||
Risk Grade | U | |||
Reward Grade | U | |||
Rating Factors | ABRT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Unrated | |||
Growth Index | Unrated | |||
Efficiency Index | Unrated | |||
Solvency Index | Unrated | |||
Total Return Index | Unrated | |||
Volatility Index | Unrated | |||
Beta / Standard Deviation | ABRT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Beta | -3.16 | |||
Price History | ABRT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 0.00% | |||
30-Day Total Return | 0.00% | |||
60-Day Total Return | 0.00% | |||
90-Day Total Return | 0.00% | |||
Year to Date Total Return | 0.00% | |||
1-Year Total Return | -66.67% | |||
2-Year Total Return | -90.00% | |||
3-Year Total Return | -98.00% | |||
5-Year Total Return | -- | |||
52-Week High % Change | -- | |||
52-Week Low % Change | -- | |||
Price | ABRT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | -- | |||
52-Week Low Price | -- | |||
52-Week Low Price (Date) | Mar 13, 2025 | |||
52-Week High Price (Date) | Mar 13, 2025 | |||
Valuation | ABRT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 258.67K | |||
Enterprise Value | 265.63K | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.04 | |||
Earnings Per Share Growth | -64.26% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | -- | |||
Price/Book (Q) | -1.14 | |||
Enterprise Value/Revenue (TTM) | -- | |||
Price | $0.01 | |||
Enterprise Value/EBITDA (TTM) | -0.16 | |||
Enterprise Value/EBIT | -0.16 | |||
Market Cap Category | Nano Cap | |||
Dividends and Shares | ABRT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 74.41M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | ABRT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 778 819 0740 | |||
Address | 201-6996 Merritt Avenue Burnaby, BC V5J 4R6 | |||
Website | albertlabs.com | |||
Country | Canada | |||
Year Founded | -- | |||
Profitability | ABRT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -- | |||
Profit Margin | -- | |||
Management Effectiveness | ABRT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -430.74% | |||
Return on Equity | -- | |||
Income Statement | ABRT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | -- | |||
Total Revenue (TTM) | -- | |||
Revenue Per Share | -- | |||
Gross Profit (TTM) | -- | |||
EBITDA (TTM) | -1.70M | |||
EBIT (TTM) | -1.71M | |||
Net Income (TTM) | -1.70M | |||
Net Income Avl. to Common (TTM) | -1.70M | |||
Total Revenue Growth (Q YOY) | -- | |||
Earnings Growth (Q YOY) | 96.93% | |||
EPS Diluted (TTM) | -0.04 | |||
EPS Diluted Growth (Q YOY) | 96.67% | |||
Balance Sheet | ABRT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 100.00 | |||
Cash Per Share (Q) | $0.00 | |||
Total Current Assets (Q) | 9.50K | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | -327.50K | |||
Current Ratio (Q) | 0.025 | |||
Book Value Per Share (Q) | $0.00 | |||
Total Assets (Q) | 47.80K | |||
Total Current Liabilities (Q) | 375.30K | |||
Total Debt (Q) | 7.50K | |||
Total Liabilities (Q) | 375.30K | |||
Total Common Equity (Q) | -327.50K | |||
Cash Flow | ABRT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | 14.80K | |||
Cash from Financing (TTM) | 251.50K | |||
Net Change in Cash (TTM) | -78.20K | |||
Levered Free Cash Flow (TTM) | -1.13M | |||
Cash from Operations (TTM) | -378.80K | |||